Kenneth Harris has stepped down as president of Cesca Therapeutics Inc., the Rancho Cordova medical technology company.
The company said Harris also left the firm’s U.S. board of directors but “will remain involved with the company as an independent adviser for up to 18 months.”
In mid-September, the company reported a $2.4 million loss for its fiscal fourth quarter, just days after laying off 15 workers as part of an effort to trim annual expenses by $3.3 million.
For the full fiscal year, Cesca’s losses totaled $14.9 million.
Cesca does research, development and commercialization of products used in regenerative medicine.